Mirae Asset Global ETFs Holdings’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30K Sell
91,418
-16,049
-15% -$25.2K ﹤0.01% 2997
2025
Q4
$334K Buy
107,467
+20,193
+23% +$57.6K ﹤0.01% 2102
2025
Q3
$230K Sell
87,274
-16,673
-16% -$36.8K ﹤0.01% 2255
2025
Q2
$128K Buy
+103,947
New +$113K ﹤0.01% 2484

Other funds holding GOSS

Mirae Asset Global ETFs Holdings's GOSS Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Gossamer Bio (GOSS) stake by 15% in Q1 2026, selling an estimated $25.2K and leaving 91,418 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #2997.

Mirae Asset Global ETFs Holdings first reported a position in GOSS in Q2 2025 and has held it in 4 quarters since. The position peaked at $334K in Q4 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 91,418 shares of Gossamer Bio worth $30K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings sold 16,049 Gossamer Bio shares in Q1 2026, an estimated $25.2K.
  • Gossamer Bio made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2997 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Gossamer Bio in Q2 2025 and has held it in 4 quarters since.
  • Mirae Asset Global ETFs Holdings's Gossamer Bio position peaked at $334K in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.